List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 40 studies with search of: Open Studies | "Eye Neoplasms"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Condition: Eye Cancer
Interventions: Procedure: Lymphatic Mapping;   Procedure: SLN Mapping/Biopsy
2 Recruiting Social-Psychological Aspects of Orbital Exenteration
Condition: Eye Cancer
Interventions: Behavioral: Audio-Taped Interview;   Behavioral: Questionnaire
3 Recruiting Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Conditions: Retinoblastoma;   Retinal Neoplasm
Interventions: Procedure: Enucleation;   Drug: Vincristine, Carboplatin;   Procedure: Focal Therapies;   Radiation: External Beam Radiation;   Drug: Vincristine + Topotecan;   Drug: Vincristine + Carboplatin + Etoposide;   Drug: Vincristine + Cyclophosphamide + Doxorubicin;   Drug: Vincristine+Carboplatin+Etoposide;   Procedure: Periocular carboplatin;   Other: G-CSF
4 Recruiting Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
Condition: Retinoblastoma
Interventions: Radiation: Proton Beam Radiation Therapy;   Procedure: Ophthalmic EUA
5 Not yet recruiting Treatment Of Radiation Retinopathy Trial
Condition: Uveal Melanoma
Interventions: Drug: ranibizumab;   Drug: triamcinolone acetonide;   Other: sham
6 Recruiting Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: dendritic cell vaccine therapy;   Biological: therapeutic autologous lymphocytes;   Drug: fludarabine phosphate
7 Recruiting Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Esophageal Cancer;   Intraocular Melanoma;   Kidney Cancer;   Lymphoma;   Melanoma (Skin);   Pancreatic Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
8 Recruiting Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Condition: Uveal Melanoma
Intervention: Biological: autologous dendritic cells electroporated with mRNA
9 Recruiting Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
Conditions: Uveal Melanoma;   Liver Metastases
Interventions: Drug: GM-CSF;   Procedure: Embolization
10 Recruiting Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
Conditions: Intraocular Melanoma;   Metastatic Cancer
Interventions: Drug: fotemustine;   Drug: isolated perfusion
11 Not yet recruiting Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
Condition: Intraocular Melanoma
Interventions: Genetic: fluorescence in situ hybridization;   Other: laboratory biomarker analysis;   Procedure: fine-needle aspiration;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy
12 Recruiting Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
Condition: Metastatic Malignant Uveal Melanoma
Intervention: Drug: Marqibo® (vincristine sulfate liposomes injection)
13 Recruiting Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Head and Neck Cancer;   Intraocular Melanoma;   Melanoma (Skin);   Non-melanomatous Skin Cancer;   Precancerous Condition
Interventions: Genetic: DNA ploidy analysis;   Genetic: mutation analysis
14 Recruiting Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Condition: Intraocular Melanoma
Interventions: Drug: cisplatin;   Drug: sunitinib malate;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
15 Recruiting Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer;   Gastrointestinal Stromal Tumor;   Intraocular Melanoma;   Kidney Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: dasatinib
16 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Condition: Intraocular Melanoma
Intervention: Drug: paclitaxel albumin-stabilized nanoparticle formulation
17 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8
18 Recruiting Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Dietary Supplement: calcitriol;   Drug: temozolomide
19 Recruiting Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Intraocular Melanoma;   Malignant Conjunctival Neoplasm;   Melanoma (Skin)
Interventions: Biological: MART-1:27-35 peptide vaccine;   Biological: gp100:209-217(210M) peptide vaccine;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Biological: tyrosinase peptide;   Drug: agatolimod sodium;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis
20 Not yet recruiting Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: sunitinib malate;   Drug: temozolomide

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services